Medical Equipment News

Medical Segment Revenue Grows 231% Year-Over-Year Enters Strategic Distribution Agreement to Expand CompuFlo® Access Across VA and Department of Defense Health Systems Reaffirms 2026 Outlook for...

FocalTherics™ Reports Second Quarter 2026 Financial Results 39% Revenue Increase and 47% Growth in U.S. Procedures AUSTIN, Texas, Aug. 13, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (Nasdaq: FOCL)...

FORT LAUDERDALE, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- via IBN – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic...

WallabyPhenox Announces First Patient Enrolled in PROMISE Study Evaluating Treatment of Medium Vessel Occlusion Stroke

10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Second Quarter 2026; Backlog of 13 ALLY Systems as of June 30, 2026 Second Quarter Recurring Revenue was $13.7 million Total...

SYMON-II pivotal clinical study completes targeted enrollment of 750 patientsCompany advances toward planned 510(k) submission and commercialization with US manufacturing contract signed to mitigate...

BioStem Technologies Reports Second Quarter 2026 Financial Results

明尼苏达州圣 保罗, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Egg Medical 宣布，Rampart IC, LLC (“Rampart”) 已撤回对美国专利商标局 (USPTO) 复审裁定的上诉。该裁定认定 Rampart 美国专利第 11,660,056 号原授权权利要求无效。USPTO 的无效裁定的依据是，‘056 专利中的发明要么此前已由他人（包括...

明尼蘇達州 聖保羅, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Egg Medical 宣佈，Rampart IC, LLC（「Rampart」）已撤回其對美國專利商標局 (USPTO) 複審裁決的上訴。該裁決認定 Rampart 所持有的美國專利第 11,660,056 號原授權權利項為無效。USPTO 作出無效裁決的理據在於，已核發的『056...

ST. PAUL, Minnesota, 12 août 2026 (GLOBE NEWSWIRE) -- Egg Medical a annoncé que Rampart IC, LLC (« Rampart ») avait retiré son recours contre la décision de réexamen de l’USPTO, selon laquelle...